Work

The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers

Year: 2025

Type: article

Source: Clinical and Translational Medicine

DOI: 10.1002/ctm2.70223

Authors: Ronan J. Kelly, Valsamo Anagnostou, Vincent K. Lam, Ali H. Zaidi

Institutions: Baylor University Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Allegheny Health Network

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,470

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Gilead Sciences, Johns Hopkins University, Myriad Genetics, National Institutes of Health, Genentech, Foundation Medicine, National Cancer Institute

Awards: G3169672230, ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center, Large-Scale Genetic Analyses of Human Cancer, G7403241455

OpenAlex ID: W4407140575

FWCI:

Cites: 5

Cited by:

Related to: 10